Literature DB >> 3976520

Multifactorial determinants of reduced coronary flow reserve after dipyridamole in dilated cardiomyopathy.

A Nitenberg, J M Foult, F Blanchet, S Zouioueche.   

Abstract

Coronary sinus blood flow (ml/100 g left ventricular [LV] mass/min) and coronary resistance (mean aortic minus LV mean diastolic pressures/coronary sinus blood flow, mm Hg/[ml/100 g/min]) were studied in 7 control patients and in 11 patients with severe dilated cardiomyopathy (DC) and normal coronary arteriograms. Basal coronary sinus blood flow was not different in the 2 groups. After intravenous administration of dipyridamole (0.14 mg/kg/min X 4 min), coronary sinus blood flow and dipyridamole/basal coronary sinus blood flow ratio were significantly (p less than 0.001) lower in the DC group than in the normal group (coronary sinus blood flow 188 +/- 48 vs 408 +/- 58, respectively; blood flow ratio 1.78 +/- 0.35 vs 4.01 +/- 0.56, respectively), and the coronary resistance was higher in the DC group than in the control group (0.39 +/- 0.15 vs 0.22 +/- 0.03, respectively, p less than 0.01). After administration of dipyridamole in patients with DC, no correlation could be found between coronary sinus blood flow and LV mean diastolic, mean aortic or coronary driving pressures, i.e., mean aortic minus LV mean diastolic pressures. Thus, in DC patients, neither an elevated LV diastolic pressure nor a low coronary perfusion pressure can totally account for the restriction of the coronary flow reserve after dipyridamole.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3976520     DOI: 10.1016/0002-9149(85)90150-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

1.  Perfusion and mechanical analysis with technetium-99m 2-methoxy-isobutyl-isonitrile in a case of dilated cardiomyopathy.

Authors:  T Takeda; H Toyama; N Ishikawa; T Masuoka; R Ajisaka; K Iida; M Satoh; W Jin; T Saitou; T Yamanouchi
Journal:  Ann Nucl Med       Date:  1992-05       Impact factor: 2.668

2.  Nebivolol improves coronary flow reserve in patients with idiopathic dilated cardiomyopathy.

Authors:  Dogan Erdogan; Hakan Gullu; Mustafa Caliskan; Ozgur Ciftci; Semra Baycan; Aylin Yildirir; Haldun Muderrisoglu
Journal:  Heart       Date:  2006-10-25       Impact factor: 5.994

3.  Coronary flow reserve in mitral stenosis before and after percutaneous balloon mitral valvuloplasty.

Authors:  Ragab A Mahfouz; Mohammad Gouda; Waleed Elawdy; Ashraf Dewedar
Journal:  Int J Cardiovasc Imaging       Date:  2017-04-04       Impact factor: 2.357

Review 4.  Left ventricular dilatation and failure post-myocardial infarction: pathophysiology and possible pharmacologic interventions.

Authors:  B G Firth; P M Dunnmon
Journal:  Cardiovasc Drugs Ther       Date:  1990-10       Impact factor: 3.727

Review 5.  PET and SPECT in heart failure.

Authors:  Christoph Rischpler; Stephan Nekolla; Markus Schwaiger
Journal:  Curr Cardiol Rep       Date:  2013-03       Impact factor: 2.931

6.  Increased production of nitric oxide in coronary arteries during congestive heart failure.

Authors:  B O'Murchu; V M Miller; M A Perrella; J C Burnett
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

7.  Effect of streptozotocin-induced diabetes on myocardial blood flow reserve assessed by myocardial contrast echocardiography in rats.

Authors:  Bernard Cosyns; Steven Droogmans; Sophie Hernot; Céline Degaillier; Christian Garbar; Caroline Weytjens; Bram Roosens; Danny Schoors; Tony Lahoutte; Philippe R Franken; Guy Van Camp
Journal:  Cardiovasc Diabetol       Date:  2008-09-02       Impact factor: 9.951

8.  Myocardial contrast echocardiography for the detection of coronary artery disease in patients with global hypokinesis admitted for first-onset acute heart failure: pilot study.

Authors:  Sung Eun Kim; Dae-Gyun Park; Ji Yeon Hong; Jun Hee Lee; Kyoo Rok Han; Dong Jin Oh
Journal:  J Cardiovasc Ultrasound       Date:  2014-09-29

9.  Effects of Epicardial and Endocardial Cardiac Resynchronization Therapy on Coronary Flow: Insights From Wave Intensity Analysis.

Authors:  Simon Claridge; Zhong Chen; Tom Jackson; Kalpa De Silva; Jonathan Behar; Manav Sohal; Jessica Webb; Eoin Hyde; Matthew Lumley; Kal Asrress; Rupert Williams; Julian Bostock; Motin Ali; Jaswinder Gill; Mark O'Neill; Reza Razavi; Steve Niederer; Divaka Perera; Christopher Aldo Rinaldi
Journal:  J Am Heart Assoc       Date:  2015-12-17       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.